Education
About Us
Working with TipRanks
Follow Us
Lytix Biopharma AS (DE:6BG)
FRANKFURT:6BG
Ltx-315 In Combination With Pembrolizumab
Advanced Melanoma
Phase II
Unknown
Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma
Mar 02, 2021
―
Ltx-315 And Tils
Soft Tissue Sarcoma
Phase II
Completed
LTX-315 and Adoptive T-cell Therapy in Advanced Soft Tissue Sarcoma (ATLAS-IT-04)
Oct 02, 2018
―
Ltx-315 Consecutive Lesions, Ltx-315, Ltx-315 + Ipilimumab, Ltx-315 + Pembrolizumab
Cancer, Breast Cancer, Melanoma, Lymphoma, Head And Neck Cancer, Triple-Negative Breast Cancer
Phase I
Completed
LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab
Oct 28, 2013
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Lytix Biopharma AS (6BG) have in its pipeline
6BG is currently developing the following drugs: Ltx-315 In Combination With Pembrolizumab, Ltx-315 And Tils, Ltx-315 Consecutive Lesions, Ltx-315, Ltx-315 + Ipilimumab, Ltx-315 + Pembrolizumab. These drug candidates are in various stages of clinical development as the company works toward FDA approval.